“…A fixed 555-MBq (15 mCi) RAI treatment was given via oral route in patients with Graves disease, whereas a 925-MBq (25 mCi) RAI treatment was given in patients with toxic adenoma. 6,7 In addition, patients were prescribed a diet with low iodine content 10 days before the therapy, and antithyroid medications were withdrawn 7 days before the therapy. 1,7 In all patients, ophthalmological examination, Schirmer test, TBUT test, and ocular surface examination were performed before and at 3 and 6 months after RAI treatment, and results were prospectively evaluated.…”